IS5482A - Samsetning af virkum efnisþáttum sérstaklega af tetrahýdrópýridínum og asetýlkólín esterasa hindrandi miðlun til meðhöndlunar á elliglöpum á borð viðAlzheimers vitglöp - Google Patents
Samsetning af virkum efnisþáttum sérstaklega af tetrahýdrópýridínum og asetýlkólín esterasa hindrandi miðlun til meðhöndlunar á elliglöpum á borð viðAlzheimers vitglöpInfo
- Publication number
- IS5482A IS5482A IS5482A IS5482A IS5482A IS 5482 A IS5482 A IS 5482A IS 5482 A IS5482 A IS 5482A IS 5482 A IS5482 A IS 5482A IS 5482 A IS5482 A IS 5482A
- Authority
- IS
- Iceland
- Prior art keywords
- dementia
- tetrahydropyridine
- alzheimer
- treatment
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9714322A FR2771007B1 (fr) | 1997-11-14 | 1997-11-14 | Association de principes actifs pour le traitement de la demence senile du type alzheimer |
FR9714324A FR2771006B1 (fr) | 1997-11-14 | 1997-11-14 | Association de principes actifs pour le traitement de la demence senile du type alzheimer |
PCT/FR1998/002384 WO1999025363A1 (fr) | 1997-11-14 | 1998-11-09 | Association de principes actifs, notamment de tetrahydropyridines et d'agents inhibiteurs de l'acetylcholinesterase, pour le traitement de la demence senile du type alzheimer |
Publications (1)
Publication Number | Publication Date |
---|---|
IS5482A true IS5482A (is) | 2000-05-09 |
Family
ID=26233932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS5482A IS5482A (is) | 1997-11-14 | 2000-05-09 | Samsetning af virkum efnisþáttum sérstaklega af tetrahýdrópýridínum og asetýlkólín esterasa hindrandi miðlun til meðhöndlunar á elliglöpum á borð viðAlzheimers vitglöp |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1030671A1 (is) |
JP (1) | JP2001523642A (is) |
KR (1) | KR100599350B1 (is) |
CN (1) | CN1243540C (is) |
AU (1) | AU743228B2 (is) |
BG (1) | BG64819B1 (is) |
BR (1) | BR9814035A (is) |
CA (1) | CA2309966A1 (is) |
CO (1) | CO4980891A1 (is) |
DZ (1) | DZ2649A1 (is) |
EA (1) | EA003255B1 (is) |
EE (1) | EE04235B1 (is) |
HU (1) | HUP0100098A3 (is) |
ID (1) | ID24933A (is) |
IL (2) | IL136122A0 (is) |
IS (1) | IS5482A (is) |
MY (1) | MY120461A (is) |
NO (1) | NO20002450L (is) |
NZ (1) | NZ504420A (is) |
OA (1) | OA11464A (is) |
PL (1) | PL194597B1 (is) |
SA (1) | SA98190747B1 (is) |
SK (1) | SK286040B6 (is) |
TR (1) | TR200001262T2 (is) |
TW (1) | TW585766B (is) |
UY (1) | UY25247A1 (is) |
WO (1) | WO1999025363A1 (is) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100375619C (zh) * | 2002-06-14 | 2008-03-19 | 富山化学工业株式会社 | 改善脑功能的药物组合物及其用途 |
PT1529116E (pt) * | 2002-08-07 | 2009-09-10 | Novartis Ag | Métodos para o tratamento da demência com base no genótipo da apo e |
CN1520818A (zh) * | 2003-02-09 | 2004-08-18 | 山东绿叶天然药物研究开发有限公司 | 治疗老年性痴呆的胆碱酯酶抑制剂药物组合物 |
JP2008525313A (ja) | 2004-12-27 | 2008-07-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗痴呆薬の安定化方法 |
DK3498692T3 (da) | 2014-01-31 | 2022-05-16 | Cognition Therapeutics Inc | Isoindolin-sammensætninger og fremgangsmåder til behandling af neurodegenerativ sygdom og makulær degeneration |
BR112019023851A2 (pt) * | 2017-05-15 | 2020-08-18 | Cognition Therapeutics, Inc. | compostos, suas composições farmacêuticas e métodos para tratamento de doenças neurodegenerativas |
WO2019182319A1 (ko) * | 2018-03-20 | 2019-09-26 | (주)인벤티지랩 | 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물 |
KR102224917B1 (ko) | 2018-03-20 | 2021-03-09 | (주)인벤티지랩 | 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물 |
CN109265391B (zh) * | 2018-11-13 | 2021-11-19 | 枣庄学院 | 联苯多取代1,2,5,6-四氢吡啶化合物及其合成方法与应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2662355B1 (fr) * | 1990-05-22 | 1994-11-10 | Sanofi Sa | Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux. |
US5453428A (en) * | 1991-02-14 | 1995-09-26 | The Mount Sinai School Of Medicine Of The City Of New York | Method and composition for the treatment of apathy-amotivation syndrome |
CN1126546C (zh) * | 1995-03-06 | 2003-11-05 | 英特纽隆制剂药有限公司 | 使用胞磷胆碱减少梗塞面积 |
FR2736053B1 (fr) * | 1995-06-28 | 1997-09-19 | Sanofi Sa | Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines |
-
1998
- 1998-10-26 CO CO98062479A patent/CO4980891A1/es unknown
- 1998-10-28 TW TW087117874A patent/TW585766B/zh not_active IP Right Cessation
- 1998-11-09 AU AU11609/99A patent/AU743228B2/en not_active Ceased
- 1998-11-09 SK SK711-2000A patent/SK286040B6/sk unknown
- 1998-11-09 KR KR1020007005231A patent/KR100599350B1/ko not_active IP Right Cessation
- 1998-11-09 BR BR9814035-3A patent/BR9814035A/pt not_active Application Discontinuation
- 1998-11-09 TR TR2000/01262T patent/TR200001262T2/xx unknown
- 1998-11-09 PL PL98340500A patent/PL194597B1/pl not_active IP Right Cessation
- 1998-11-09 EE EEP200000290A patent/EE04235B1/xx not_active IP Right Cessation
- 1998-11-09 CN CNB988130947A patent/CN1243540C/zh not_active Expired - Fee Related
- 1998-11-09 HU HU0100098A patent/HUP0100098A3/hu unknown
- 1998-11-09 EP EP98954538A patent/EP1030671A1/fr not_active Withdrawn
- 1998-11-09 EA EA200000412A patent/EA003255B1/ru not_active IP Right Cessation
- 1998-11-09 IL IL13612298A patent/IL136122A0/xx not_active IP Right Cessation
- 1998-11-09 ID IDW20000860A patent/ID24933A/id unknown
- 1998-11-09 CA CA002309966A patent/CA2309966A1/en not_active Abandoned
- 1998-11-09 NZ NZ504420A patent/NZ504420A/en unknown
- 1998-11-09 JP JP2000520796A patent/JP2001523642A/ja not_active Withdrawn
- 1998-11-09 WO PCT/FR1998/002384 patent/WO1999025363A1/fr not_active Application Discontinuation
- 1998-11-11 DZ DZ980259A patent/DZ2649A1/xx active
- 1998-11-12 UY UY25247A patent/UY25247A1/es not_active IP Right Cessation
- 1998-11-14 SA SA98190747A patent/SA98190747B1/ar unknown
- 1998-11-14 MY MYPI98005180A patent/MY120461A/en unknown
-
2000
- 2000-05-09 IS IS5482A patent/IS5482A/is unknown
- 2000-05-11 NO NO20002450A patent/NO20002450L/no unknown
- 2000-05-11 BG BG104428A patent/BG64819B1/bg unknown
- 2000-05-12 OA OA1200000141A patent/OA11464A/en unknown
- 2000-05-14 IL IL136122A patent/IL136122A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1813624T3 (da) | Fremgangsmåder og sammensætninger til forebyggelse og behandling af anæmi | |
DE69612185D1 (de) | Bleichverfahren und bleichmittelzusammensetzung | |
DE69739583D1 (de) | Topische zusammensetzungen enthaltend als therapeutisch aktiven wirkstoff ein monoglycerid zur behandlung von schleimhautinfektionen | |
DK0622408T3 (da) | Sammensætning og fremgangsmåde til fremstilling af gelatinfrie, bløde kapsler | |
DE69638351D1 (de) | Sowie zur resektion des distalen und vorderen femurs | |
EP0626174A3 (en) | Method and composition for the prophylaxis and / or treatment of underactive organs. | |
DE69413051D1 (de) | Waschmittelzusammensetzungen enthaltend mittel zur verhinderung des anlaufens von silber | |
DE69718668D1 (de) | Flüssige zusammensetzung, hiv protease inhibitoren und c12-c18 fettsaure enthaltend | |
WO2000066104A3 (en) | Ace-2 inhibiting compounds and methods of use thereof | |
DE69617088D1 (de) | Verfahren zur Herstellung von kristallisiertem Maltit und diesen enthaltenden Kristallinen. | |
DK0926952T3 (da) | Antimikrobiel sammensætning og fremgangsmåde til fremstilling deraf | |
DE69812784D1 (de) | Zusammensetzung zur Vorbeugung und Beseitigung von Pflanzenkrankheiten | |
GB9706842D0 (en) | Pharmaceutical compositions for the treatment of rhinitis | |
AU1509999A (en) | Herbal drug composition for the prevention and treatment of dementia | |
ZA977310B (en) | Transdermal propentofylline compositions for the treatment of Alzheimer's disease. | |
IS5482A (is) | Samsetning af virkum efnisþáttum sérstaklega af tetrahýdrópýridínum og asetýlkólín esterasa hindrandi miðlun til meðhöndlunar á elliglöpum á borð viðAlzheimers vitglöp | |
DE69831788D1 (de) | Verfahren zur Herstellung von halbtransparanten Mischungen aus Poly-Phenyleoxyden und Styrencopolymeren | |
DE69405919D1 (de) | Zusammensetzungen zur Behandlung von Keratinfasern | |
DE69420229D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung von AIDS | |
DE69403737D1 (de) | Organosiloxan-Zusammensetzung und Herstellungsverfahren | |
DK1007040T3 (da) | Anvendelsen af phanquinon til behandlingen af Alzheimers sygdom | |
NO992504D0 (no) | Sammensetninger for behandling av jord, fremgangsmÕte for fremstilling derav, samt anvendelse | |
NO20001758D0 (no) | Fremgangsmåter og blandinger for behandling av leddgikt | |
WO2000033788A3 (en) | Substituted nitrogen heterocyclic compounds and therapeutic uses thereof | |
EP0635567A3 (en) | Method and composition for facilitating the removal of stains from solid surfaces. |